A PREDICTIVE MODEL FOR THE CLINICAL-RESPONSE TO LOW-DOSE ARA-C - A STUDY OF 102 PATIENTS WITH MYELODYSPLASTIC SYNDROMES OR ACUTE-LEUKEMIA

被引：0
|
作者：
HELLSTROMLINDBERG, E
ROBERT, KH
GAHRTON, G
LINDBERG, G
FORSBLOM, AM
KOCK, Y
OST, A
机构：
[1] HUDDINGE UNIV HOSP,DEPT MED,S-14186 HUDDINGE,SWEDEN
[2] HUDDINGE UNIV HOSP,DEPT CYTOGENET,S-14186 HUDDINGE,SWEDEN
[3] KAROLINSKA HOSP,DEPT PATHOL,S-10401 STOCKHOLM 60,SWEDEN
来源：
EXPERIMENTAL HEMATOLOGY | 1992年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：781 / 781
页数：1
相关论文
共 50 条
  • [21] RESULTS OF LOW-DOSE CYTARABINE (ARA-C) AND AGGRESSIVE CHEMOTHERAPY IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROMES
    AUL, C
    HEYLL, A
    HEYLL, U
    SCHNEIDER, W
    [J]. BLUT, 1988, 56 (06): : C19 - C19
  • [22] EFFECT OF LOW-DOSE ARA-C TREATMENT AND THE COMBINATION TREATMENT WITH LOW-DOSE ARA-C AND HYDROXYVITAMIN-D3 IN ACUTE NONLYMPHOCYTIC LEUKEMIA AND MYELODYSPLASTIC SYNDROME
    SAWADA, H
    ABE, T
    TASHIMA, M
    YOSHIDA, Y
    YAMAGISHI, M
    OKUDA, T
    YUMOTO, Y
    KATO, Y
    UCHINO, H
    [J]. MYELODYSPLASTIC SYNDROMES : PATHOPHYSIOLOGY AND TREATMENT, 1988, 783 : 205 - 214
  • [23] LOW-DOSE ARA-C THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA IN ELDERLY PATIENTS
    POWELL, BL
    CAPIZZI, RL
    MUSS, HB
    BEARDEN, JD
    LYERLY, ES
    ROSENBAUM, DL
    MORGAN, TM
    RICHARDS, F
    JACKSON, DV
    WHITE, DR
    NELSON, EC
    BUTLER, WM
    ZEKAN, PJ
    CRUZ, JM
    COOPER, MR
    BUSS, DH
    SPURR, CL
    [J]. LEUKEMIA, 1989, 3 (01) : 23 - 28
  • [24] LOW-DOSE ARA-C IN THE TREATMENT OF ACUTE-LEUKEMIA CYTO-TOXICITY OR DIFFERENTIATION INDUCTION
    HOELZER, D
    GANSER, A
    ANGER, B
    SEIFRIED, E
    HEIMPEL, H
    [J]. BLUT, 1984, 48 (04): : 233 - 238
  • [25] Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia
    Dennis, Mike
    Russell, Nigel
    Hills, Robert K.
    Hemmaway, Claire
    Panoskaltsis, Nicki
    McMullin, Mary-Frances
    Kjeldsen, Lars
    Dignum, Helen
    Thomas, Ian F.
    Clark, Richard E.
    Milligan, Don
    Burnett, Alan K.
    [J]. BLOOD, 2015, 125 (19) : 2923 - 2932
  • [26] HIGH-DOSE ARA-C TREATMENT OF PATIENTS WITH ACUTE-LEUKEMIA
    HENKE, M
    HECHT, T
    EMMERICH, BS
    BROSS, KJ
    LOHR, GW
    [J]. BLUT, 1987, 55 (04): : 313 - 313
  • [27] A THERAPEUTIC TRIAL WITH LOW-DOSE CYTARABINE IN MYELODYSPLASTIC SYNDROMES AND ACUTE-LEUKEMIA
    INBAL, A
    JANUSZEWICZ, E
    RABINOWICTZ, M
    SHAKLAI, M
    [J]. ACTA HAEMATOLOGICA, 1985, 73 (02) : 71 - 74
  • [28] LOW-DOSE ARA-C(LODAC) IN ACUTE MYELOID-LEUKEMIA
    AMADORI, S
    PETTI, MC
    AVVISATI, G
    SIKOGLOU, N
    MANDELLI, F
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 185 - 185
  • [29] LOW-DOSE ARA-C IN ACUTE NON-LYMPHOBLASTIC LEUKEMIA
    BUCK, M
    VINCENT, PC
    YOUNG, GAR
    BENSON, WJ
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1984, 12 (04): : 295 - 295
  • [30] PREDICTORS OF RESPONSE TO LOW-DOSE ARA-C
    MILLER, KB
    GRUNWALD, H
    LARSON, R
    RAZA, A
    GOLDBERG, J
    VOGLER, R
    BENNETT, J
    BROWMAN, G
    PREISLER, HD
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 236 - 236
12345